TMO — Thermo Fisher Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- $215.19bn
- $247.46bn
- $42.88bn
- 93
- 25
- 92
- 81
Annual cashflow statement for Thermo Fisher Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 6,375 | 7,728 | 6,960 | 5,955 | 6,338 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 536 | 1,187 | 857 | 882 | 809 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -395 | -1,548 | -1,049 | -537 | -379 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 8,289 | 9,312 | 9,154 | 8,406 | 8,667 |
| Capital Expenditures | -1,474 | -2,523 | -2,243 | -1,479 | -1,400 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -36 | -19,409 | 84 | -3,663 | -4,441 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,510 | -21,932 | -2,159 | -5,142 | -5,841 |
| Financing Cash Flow Items | -147 | -91 | -9 | 56 | 194 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 959 | 6,581 | -2,810 | -3,622 | -6,792 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7,914 | -5,845 | 4,046 | -440 | -4,057 |